• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝实质细胞特异性 Smad4 缺失通过促进 CXCL10/CXCR3 依赖的 CD8+T 细胞介导的抗肿瘤免疫抑制肝癌发生。

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8- T cell-mediated anti-tumor immunity.

机构信息

The College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing, China.

Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.

出版信息

Theranostics. 2024 Sep 9;14(15):5853-5868. doi: 10.7150/thno.97276. eCollection 2024.

DOI:10.7150/thno.97276
PMID:39346534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11426237/
Abstract

Sma mothers against decapentaplegic homologue 4 (Smad4) is a key mediator of the transforming growth factor β (TGF-β) pathway and plays complex and contradictory roles in hepatocellular carcinoma (HCC). However, the specific role of Smad4 in hepatocytes in regulating hepatocarcinogenesis remains poorly elucidated. A diethylnitrosamine/carbon tetrachloride-induced HCC model was established in mice with hepatocyte-specific Smad4 deletion (Alb) and liver tumorigenesis was monitored. Immune cell infiltration was examined by immunofluorescence and fluorescence activated cell sorting (FACS). Cytokine secretion, glycolysis, signal pathway, and single-cell RNA sequencing were analysed for mechanism. Alb mice exhibited significantly fewer and smaller liver tumor nodules, less fibrosis, reduced myeloid-derived suppressor cell infiltration and increased CD8 T cell infiltration. Smad4 deletion in hepatocytes enhanced C-X-C motif ligand 10 (CXCL10) secretion, promoting tumor necrosis factor-α (TNF-α) production in CD8 T cells. The loss of Smad4 activated the CXCL10/mammalian target of rapamycin (mTOR)/lactate dehydrogenase A (LDHA) pathway, which increased glycolytic activity in CD8 T cells. HCC patients with high Smad4 expression exhibited decreased CD8 T cell infiltration and altered glycolysis. Our results demonstrate that Smad4 in hepatocytes promotes hepatocarcinogenesis and is a potential and candidate target for the prevention and therapy of HCC.

摘要

Sma 母亲对抗 decapentaplegic 同源物 4(Smad4)是转化生长因子 β(TGF-β)途径的关键介质,在肝细胞癌(HCC)中发挥复杂而矛盾的作用。然而,Smad4 在肝细胞中调节肝癌发生的具体作用仍不清楚。

我们在具有肝细胞特异性 Smad4 缺失(Alb)的小鼠中建立了二乙基亚硝胺/四氯化碳诱导的 HCC 模型,并监测了肝肿瘤发生情况。通过免疫荧光和荧光激活细胞分选(FACS)检查免疫细胞浸润情况。分析了细胞因子分泌、糖酵解、信号通路和单细胞 RNA 测序,以探讨其机制。

Alb 小鼠的肝肿瘤结节数量明显减少且体积较小,纤维化程度降低,髓系来源抑制细胞浸润减少,CD8 T 细胞浸润增加。肝细胞中 Smad4 的缺失增强了 C-X-C 基序配体 10(CXCL10)的分泌,促进了 CD8 T 细胞中肿瘤坏死因子-α(TNF-α)的产生。Smad4 的缺失激活了 CXCL10/哺乳动物雷帕霉素靶蛋白(mTOR)/乳酸脱氢酶 A(LDHA)通路,增加了 CD8 T 细胞的糖酵解活性。Smad4 高表达的 HCC 患者表现出 CD8 T 细胞浸润减少和糖酵解改变。

我们的研究结果表明,肝细胞中的 Smad4 促进了肝癌的发生,是预防和治疗 HCC 的潜在候选靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/bda09ee8886b/thnov14p5853g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/8d7dfd39dc32/thnov14p5853g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/eb0010cfa71d/thnov14p5853g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/f0c14869cda3/thnov14p5853g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/7fa93f50a060/thnov14p5853g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/2f67c936140f/thnov14p5853g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/98e032b7fdb4/thnov14p5853g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/bda09ee8886b/thnov14p5853g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/8d7dfd39dc32/thnov14p5853g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/eb0010cfa71d/thnov14p5853g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/f0c14869cda3/thnov14p5853g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/7fa93f50a060/thnov14p5853g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/2f67c936140f/thnov14p5853g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/98e032b7fdb4/thnov14p5853g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e62/11426237/bda09ee8886b/thnov14p5853g007.jpg

相似文献

1
Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8- T cell-mediated anti-tumor immunity.肝实质细胞特异性 Smad4 缺失通过促进 CXCL10/CXCR3 依赖的 CD8+T 细胞介导的抗肿瘤免疫抑制肝癌发生。
Theranostics. 2024 Sep 9;14(15):5853-5868. doi: 10.7150/thno.97276. eCollection 2024.
2
Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.肝癌中浆细胞向 IgG 表型的极化涉及表观遗传改变,并促进小鼠肝癌进展。
Gastroenterology. 2019 May;156(6):1890-1904.e16. doi: 10.1053/j.gastro.2019.01.250. Epub 2019 Jan 31.
3
Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).干扰素调节因子 1(IRF-1)通过 CXCL10/CXCR3 轴在肝细胞癌(HCC)中激活抗肿瘤免疫。
Cancer Lett. 2021 May 28;506:95-106. doi: 10.1016/j.canlet.2021.03.002. Epub 2021 Mar 6.
4
Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.肝细胞中转化生长因子-β信号的转导促进了 TAK1 肝细胞特异性缺失小鼠的肝纤维化和肝癌发生。
Gastroenterology. 2013 May;144(5):1042-1054.e4. doi: 10.1053/j.gastro.2013.01.056. Epub 2013 Feb 4.
5
Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8 T cell infiltration.内皮细胞黏附分子阳性成纤维细胞通过抑制 CD8+T 细胞浸润促进肝细胞癌进展。
J Immunother Cancer. 2024 Sep 10;12(9):e009111. doi: 10.1136/jitc-2024-009111.
6
Manganese improves CD8 T cell recruitment via cGAS-STING in hepatocellular carcinoma.锰通过cGAS-STING通路改善肝癌中CD8 T细胞的募集。
Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113591. doi: 10.1016/j.intimp.2024.113591. Epub 2024 Nov 15.
7
IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.脂肪变性肝细胞和巨噬细胞中的 IL-17 信号转导促进酒精性肝病中的肝细胞癌。
J Hepatol. 2020 May;72(5):946-959. doi: 10.1016/j.jhep.2019.12.016. Epub 2019 Dec 31.
8
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4 T-Cell-Dependent Control of Senescence.CXCR6 通过促进自然杀伤 T 细胞和 CD4 T 细胞依赖的衰老控制来抑制肝癌发生。
Gastroenterology. 2019 May;156(6):1877-1889.e4. doi: 10.1053/j.gastro.2019.01.247. Epub 2019 Jan 30.
9
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma.regorafenib 联合 PD1 阻断通过诱导肝细胞癌中 CXCL10 的表达增加 CD8 T 细胞浸润。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001435.
10
CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8 T and CD8 T Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.CXCL10/CXCR3依赖性动员感染组织内的单纯疱疹病毒特异性CD8 T细胞和CD4 T细胞可有效预防复发性疱疹病毒感染和疾病。
J Virol. 2017 Jun 26;91(14). doi: 10.1128/JVI.00278-17. Print 2017 Jul 15.

引用本文的文献

1
PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC.PLAGL2作为胰腺癌的一种预后生物标志物和上皮-间质转化促进因子。
Sci Rep. 2025 Jul 14;15(1):25425. doi: 10.1038/s41598-025-09591-x.
2
Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression.肝细胞中转化生长因子-β超家族细胞因子的双信号通路:平衡肝脏内稳态与疾病进展
Front Pharmacol. 2025 Apr 7;16:1580500. doi: 10.3389/fphar.2025.1580500. eCollection 2025.
3
Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancer.

本文引用的文献

1
CircBTBD7 inhibits adipogenesis via the miR-183/SMAD4 axis.环状BTBD7通过miR-183/SMAD4轴抑制脂肪生成。
Int J Biol Macromol. 2023 Dec 31;253(Pt 2):126740. doi: 10.1016/j.ijbiomac.2023.126740. Epub 2023 Sep 9.
2
The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII.PI3K-Akt-mTOR 通路通过增强 HKII 介导的糖酵解来促进肾周细胞向肌成纤维细胞的转化。
J Transl Med. 2023 May 13;21(1):323. doi: 10.1186/s12967-023-04167-7.
3
Cancer metabolism within tumor microenvironments.
多组学分析确定DLX4作为诊断、预后和免疫浸润的新型生物标志物:从泛癌到肾癌
Discov Oncol. 2025 Apr 5;16(1):467. doi: 10.1007/s12672-025-02258-z.
肿瘤微环境中的癌症代谢。
Biochim Biophys Acta Gen Subj. 2023 May;1867(5):130330. doi: 10.1016/j.bbagen.2023.130330. Epub 2023 Feb 16.
4
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer.上皮细胞 Smad4 的缺失通过 CXCL1 驱动免疫逃逸,同时在胃癌中对联合免疫治疗显示出易感性。
Cell Rep. 2022 Dec 27;41(13):111878. doi: 10.1016/j.celrep.2022.111878.
6
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.肝肿瘤免疫微环境亚型与中性粒细胞异质性
Nature. 2022 Dec;612(7938):141-147. doi: 10.1038/s41586-022-05400-x. Epub 2022 Nov 9.
7
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.全球酒精性肝硬化和 HCC 的流行病学:趋势、预测和危险因素。
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49. doi: 10.1038/s41575-022-00688-6. Epub 2022 Oct 18.
8
Hepatocyte-Specific Smad4 Deficiency Alleviates Liver Fibrosis via the p38/p65 Pathway.肝实质细胞特异性 Smad4 缺失通过 p38/p65 通路减轻肝纤维化。
Int J Mol Sci. 2022 Oct 2;23(19):11696. doi: 10.3390/ijms231911696.
9
Oncometabolite d-2HG alters T cell metabolism to impair CD8 T cell function.代谢物 d-2HG 改变 T 细胞代谢,从而损害 CD8+T 细胞的功能。
Science. 2022 Sep 30;377(6614):1519-1529. doi: 10.1126/science.abj5104. Epub 2022 Sep 29.
10
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease.饮酒与代谢综合征:对肝脏疾病的临床和流行病学影响。
J Hepatol. 2023 Jan;78(1):191-206. doi: 10.1016/j.jhep.2022.08.030. Epub 2022 Sep 5.